Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

Rowe SM, Jackson PL, Liu G, Hardison M, Livraghi A, Solomon GM, McQuaid DB, Noerager BD, Gaggar A, Clancy JP, O'Neal W, Sorscher EJ, Abraham E, Blalock JE.

Am J Respir Crit Care Med. 2008 Oct 15;178(8):822-31. doi: 10.1164/rccm.200712-1894OC. Epub 2008 Jul 24.

2.

Emerging role of HMGB1 in fibrotic diseases.

Li LC, Gao J, Li J.

J Cell Mol Med. 2014 Dec;18(12):2331-9. doi: 10.1111/jcmm.12419. Epub 2014 Oct 6. Review.

3.

Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease.

Wagner CJ, Schultz C, Mall MA.

Mol Cell Pediatr. 2016 Dec;3(1):25. doi: 10.1186/s40348-016-0053-7. Epub 2016 Jul 25. Review.

4.

Emerging role of HMGB1 in lung diseases: friend or foe.

Ding J, Cui X, Liu Q.

J Cell Mol Med. 2017 Jun;21(6):1046-1057. doi: 10.1111/jcmm.13048. Epub 2016 Dec 31. Review.

5.

Proline-glycine-proline as a potential biomarker in chronic obstructive pulmonary disease and cystic fibrosis.

Ten Hoeve AL, Roda MA, Redegeld F, Folkerts G, Blalock JE, Gaggar A.

Tanaffos. 2012;11(2):12-5. Review.

Supplemental Content

Support Center